C. Beuvery

Rational medium design for Bordetella pertussis: basic metabolism.

C. D. de Gooijer, M. Thalen, J. van den Ijssel, 1999, Journal of biotechnology.

Dual-substrate utilization by Bordetella pertussis

C. Beuvery, R. Neeleman, M. Joerink, 2001, Applied Microbiology and Biotechnology.

Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis.

Johannes Tramper, Coen Beuvery, M. Thalen, 2006, Biologicals : journal of the International Association of Biological Standardization.

Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains.

C. Beuvery, G. Kersten, T. Hazendonk, 1999, Vaccine.

Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice.

H. Junginger, C. Beuvery, M. Fretz, 2003, Vaccine.

Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants.

C. Beuvery, T. Vesikari, G. V. van Steenis, 1994, Scandinavian journal of infectious diseases.

Quantification of cell-associated and free antigens in Bordetella pertussis suspensions by antigen binding ELISA.

M. Thalen, J. van den Ijssel, W. Jiskoot, 1997, Journal of immunoassay.

Gene‐expression‐based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production

Johannes Tramper, Mathieu Streefland, Coen Beuvery, 2009, Biotechnology and bioengineering.

Advanced process monitoring: the ultimate alternative.

R Neeleman, C Beuvery, C. Beuvery, 2002, Developments in biologicals.

Improving the cellular pertussis vaccine: increased potency and consistency.

M. Thalen, J. van den Ijssel, C. Beuvery, 2008, Vaccine.